Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
deals
4
×
gene therapy
life sciences
national blog main
national top stories
zolgensma
4
×
biotech
boston blog main
boston top stories
clinical trials
new york blog main
new york top stories
novartis
bristol-myers squibb
cancer
crispr
hemophilia
johnson & johnson
medicaid
national
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
spark therapeutics
spinal muscular atrophy
startups
abbvie
achromatopsia
acquisitions
adalimumab (humira)
adeno-associated virus
aducanumab
aduro biotech
advanced therapies
affordable care act
alexandria venture investments
alez azar
altitude life science ventures
alzheimer's disease
What
gene
therapy
remains
access
advanced
age
approval
bigger
biggest
bio
biogen’s
biopharmaceutical
capacity
car
cell
come
companies
consolidation
convo
crispr
crude
cutting
deal
despite
drug
earlier
edge
effects
emerging
encoded
failures
falcon
focus
gave
help
illumina’s
j
johnson
lasting
limited
Language
unset
Current search:
zolgensma
×
deals
×
@xconomy.com
4 years ago
CRISPR, CAR-T, Consolidation: Top Advanced Therapy Milestones of 2019
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
4 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy